123 related articles for article (PubMed ID: 23727823)
1. GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer.
Doufekas K; Hadwin R; Kandimalla R; Jones A; Mould T; Crowe S; Olaitan A; Macdonald N; Fiegl H; Wik E; Salvesen HB; Widschwendter M
Int J Gynecol Cancer; 2013 Jul; 23(6):1050-5. PubMed ID: 23727823
[TBL] [Abstract][Full Text] [Related]
2. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
[TBL] [Abstract][Full Text] [Related]
3. Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis.
Chen YC; Tsao CM; Kuo CC; Yu MH; Lin YW; Yang CY; Li HJ; Yan MD; Wang TJ; Chou YC; Su HY
Taiwan J Obstet Gynecol; 2015 Oct; 54(5):572-9. PubMed ID: 26522113
[TBL] [Abstract][Full Text] [Related]
4. Estimating the risk of endometrial cancer in symptomatic postmenopausal women: a novel clinical prediction model based on patients' characteristics.
Burbos N; Musonda P; Duncan TJ; Crocker SG; Morris EP; Nieto JJ
Int J Gynecol Cancer; 2011 Apr; 21(3):500-6. PubMed ID: 21436697
[TBL] [Abstract][Full Text] [Related]
5. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings.
Liew PL; Huang RL; Wu TI; Liao CC; Chen CW; Su PH; Wang HC; Weng YC; Lai HC
Clin Epigenetics; 2019 Nov; 11(1):170. PubMed ID: 31779688
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of sonography for detecting endometrial pathologies in postmenopausal women with and without bleeding.
Seckin B; Cicek MN; Dikmen AU; Bostancı EI; Muftuoglu KH
J Clin Ultrasound; 2016 Jul; 44(6):339-46. PubMed ID: 26857098
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of prediction models for endometrial cancer in postmenopausal bleeding.
Wong AS; Cheung CW; Fung LW; Lao TT; Mol BW; Sahota DS
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():220-4. PubMed ID: 27344124
[TBL] [Abstract][Full Text] [Related]
8. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding.
Smith-Bindman R; Weiss E; Feldstein V
Ultrasound Obstet Gynecol; 2004 Oct; 24(5):558-65. PubMed ID: 15386607
[TBL] [Abstract][Full Text] [Related]
9. Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development.
Jones A; Teschendorff AE; Li Q; Hayward JD; Kannan A; Mould T; West J; Zikan M; Cibula D; Fiegl H; Lee SH; Wik E; Hadwin R; Arora R; Lemech C; Turunen H; Pakarinen P; Jacobs IJ; Salvesen HB; Bagchi MK; Bagchi IC; Widschwendter M
PLoS Med; 2013 Nov; 10(11):e1001551. PubMed ID: 24265601
[TBL] [Abstract][Full Text] [Related]
10. Discovery and validation of methylation markers for endometrial cancer.
Wentzensen N; Bakkum-Gamez JN; Killian JK; Sampson J; Guido R; Glass A; Adams L; Luhn P; Brinton LA; Rush B; d'Ambrosio L; Gunja M; Yang HP; Garcia-Closas M; Lacey JV; Lissowska J; Podratz K; Meltzer P; Shridhar V; Sherman ME
Int J Cancer; 2014 Oct; 135(8):1860-8. PubMed ID: 24623538
[TBL] [Abstract][Full Text] [Related]
11. A Pyrosequencing Assay for the Quantitative Methylation Analysis of GALR1 in Endometrial Samples: Preliminary Results.
Kottaridi C; Koureas N; Margari N; Terzakis E; Bilirakis E; Pappas A; Chrelias C; Spathis A; Aga E; Pouliakis A; Panayiotides I; Karakitsos P
Biomed Res Int; 2015; 2015():756359. PubMed ID: 26504828
[TBL] [Abstract][Full Text] [Related]
12. Value of cervical cytology in diagnosing endometrial carcinoma in women with postmenopausal bleeding.
van Doom HC; Opmeer BC; Kooi GS; Ewing-Graham PC; Kruitwagen RF; Mol BW
Acta Cytol; 2009; 53(3):277-82. PubMed ID: 19534267
[TBL] [Abstract][Full Text] [Related]
13. [Value of ultrasonography to predict the endometrial cancer in postmenopausal bleeding].
Bouzid A; Ayachi A; Mourali M
Gynecol Obstet Fertil; 2015 Oct; 43(10):652-8. PubMed ID: 26410388
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.
Yasuda M
J Obstet Gynaecol Res; 2014 Dec; 40(12):2167-76. PubMed ID: 25363801
[TBL] [Abstract][Full Text] [Related]
15. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes.
Morelli M; Scumaci D; Di Cello A; Venturella R; Donato G; Faniello MC; Quaresima B; Cuda G; Zullo F; Costanzo F
Int J Gynecol Cancer; 2014 May; 24(4):649-58. PubMed ID: 24614826
[TBL] [Abstract][Full Text] [Related]
16. Endometrial pathology in postmenopausal women with no bleeding.
Genc M; Genc B; Sahin N; Celik E; Turan GA; Gur EB; Guclu S
Climacteric; 2015 Apr; 18(2):241-5. PubMed ID: 25017611
[TBL] [Abstract][Full Text] [Related]
17. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
Zhou XH; Teng XD; Song WY; Wu YJ
Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
[TBL] [Abstract][Full Text] [Related]
18. Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics.
Ring KL; Connor EV; Atkins KA; Ricketts W; Kashlan B; Modesitt SC
Int J Gynecol Cancer; 2013 Jun; 23(5):853-60. PubMed ID: 23552806
[TBL] [Abstract][Full Text] [Related]
19. Do postmenopausal women with thickened endometrium on trans-vaginal ultrasound in the absence of vaginal bleeding need hysteroscopic assessment? A Pilot Study.
Laiyemo R; Dudill W; Jones SE; Browne H
J Obstet Gynaecol; 2016; 36(2):223-6. PubMed ID: 26466745
[TBL] [Abstract][Full Text] [Related]
20. The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers.
Hinshaw HD; Smith A; Rungruang B; Kelley JL; Beriwal S; Krivak TC; Sukumvanich P; Olawaiye AB
Int J Gynecol Cancer; 2013 Jul; 23(6):1044-9. PubMed ID: 23748174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]